Overview Post-operative Efficacy and Safety Study Status: Completed Trial end date: 2003-06-01 Target enrollment: Participant gender: Summary The purpose of this study was to compare the analgesic efficacy of 5 mg oxymorphone IR with placebo in patients with mild to moderate pain following outpatient knee arthroscopy. Phase: Phase 3 Details Lead Sponsor: Endo PharmaceuticalsTreatments: Oxymorphone